Featured Publications
Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients
Link MS, Sullivan RM, Olshansky B, Cannom D, Berul CI, Hauser RG, Heidbuchel H, Jordaens L, Krahn AD, Morgan J, Patton KK, Saarel EV, Wilkoff BL, Li F, Dziura J, Brandt C, Barth C, Lampert R. Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients. Circulation Arrhythmia And Electrophysiology 2021, 14: e009344. PMID: 33724879, DOI: 10.1161/circep.120.009344.Peer-Reviewed Original Research
2005
Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation
Goldberger Z, Elbel B, McPherson CA, Paltiel AD, Lampert R. Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation. Journal Of The American College Of Cardiology 2005, 46: 850-857. PMID: 16139136, DOI: 10.1016/j.jacc.2005.05.061.Peer-Reviewed Original ResearchConceptsElectrophysiologic studySingle-chamber devicesUpgrade rateMost patient populationsSingle-chamber ICDCardioverter-defibrillator implantationSingle university hospitalElectrophysiologic testingRetrospective reviewPatient populationUniversity HospitalDevice selectionInitial implantationPatientsResource utilization costsPerson costsImplantation strategyClinical needICDImplantationExpensive strategyCostly strategyPotential needUtilization costsICD/